Search Results

There are 29027 results for: content related to: Olanzapine-induced limb edema simulating episodic angioedema with eosinophilia

  1. You have full text access to this OnlineOpen article
    The Influence of Drug Physical State on the Dissolution Enhancement of Solid Dispersions Prepared Via Hot-Melt Extrusion: A Case Study Using Olanzapine

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 4, April 2014, Pages: 1214–1223, Maria Fátima Pina, Min Zhao, João F. Pinto, João J. Sousa and Duncan Q. M. Craig

    Version of Record online : 7 FEB 2014, DOI: 10.1002/jps.23894

  2. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease

    International Journal of Geriatric Psychiatry

    Volume 19, Issue 2, February 2004, Pages: 115–126, Peter Paul De Deyn, Manuel Martín Carrasco, Walter Deberdt, Claude Jeandel, Donald P. Hay, Peter D. Feldman, Carrie A. Young, Deborah L. Lehman and Alan Breier

    Version of Record online : 28 JAN 2004, DOI: 10.1002/gps.1032

  3. Olanzapine plus fluoxetine treatment alters mitochondrial respiratory chain activity in the rat brain

    Acta Neuropsychiatrica

    Volume 23, Issue 6, December 2011, Pages: 282–291, Fabiano R. Agostinho, Gislaine Z. Réus, Roberto B. Stringari, Karine F. Ribeiro, Gabriela K. Ferreira, Isabela C. Jeremias, Giselli Scaini, Gislaine T. Rezin, Emílio L. Streck and João Quevedo

    Version of Record online : 30 JUN 2011, DOI: 10.1111/j.1601-5215.2011.00569.x

  4. You have free access to this content
    Profiling of Energy Metabolism in Olanzapine-Induced Weight Gain in Rats and Its Prevention by the CB1-Antagonist AVE1625


    Volume 18, Issue 10, October 2010, Pages: 1952–1958, Michaela Liebig, Matthias Gossel, Jeremy Pratt, Mark Black, Guido Haschke, Ralf Elvert, Hans-Paul Juretschke, Claudia Neumann-Haefelin, Werner Kramer and Andreas W. Herling

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2010.17

  5. You have free access to this content
    Indirect comparison analysis of efficacy and safety between olanzapine and aripiprazole for schizophrenia

    British Journal of Clinical Pharmacology

    Volume 77, Issue 5, May 2014, Pages: 767–776, Taro Kunitomi, Masayuki Hashiguchi and Mayumi Mochizuki

    Version of Record online : 22 APR 2014, DOI: 10.1111/bcp.12221

  6. Isolation and characterization of process related impurities of olanzapine using HPLC and ESI-MS/MS

    Journal of Separation Science

    Volume 31, Issue 1, January 2008, Pages: 107–118, Ramisetti Nageswara Rao, Ale Narasa Raju, Ramaram Narsimha and Ganduri Raveendra Babu

    Version of Record online : 13 DEC 2007, DOI: 10.1002/jssc.200700397

  7. You have free access to this content
    Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men


    Volume 18, Issue 8, August 2010, Pages: 1646–1651, Robert J. Fountaine, Ann E. Taylor, James P. Mancuso, Frank L. Greenway, Lauri O. Byerley, Steven R. Smith, Marlene M. Most and David A. Fryburg

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2010.6

  8. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial

    International Journal of Geriatric Psychiatry

    Volume 18, Issue 11, November 2003, Pages: 1013–1020, J. S. Kennedy, D. Jeste, C. J. Kaiser, S. Golshan, G. A. Maguire, G. Tollefson, T. Sanger, F. P. Bymaster, B. J. Kinon, M. Dossenbach, J. A. Gilmore and A. Breier

    Version of Record online : 10 NOV 2003, DOI: 10.1002/gps.1007

  9. The development and validation of a method for quantifying olanzapine in human plasma by liquid chromatography tandem mass spectrometry and its application in a pharmacokinetic study

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 3, March 2015, Pages: 305–313, Noely Camila Tavares Cavalcanti Bedor, Danilo César Galindo Bedor, Carlos Eduardo Miranda de Sousa, Felipe Nunes Bonifácio, Daniel da Mota Castelo Branco, Leila Bastos Leal and Davi Pereira de Santana

    Version of Record online : 11 FEB 2015, DOI: 10.1111/1440-1681.12353

  10. Effect of Antipsychotic Medications on Glucose and Lipid Levels

    The Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2011, Pages: 631–638, Dr Parminder S. Chaggar, Dr Steven M. Shaw and Dr Simon G. Williams

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010368678

  11. Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone

    Human Psychopharmacology: Clinical and Experimental

    Volume 23, Issue 6, August 2008, Pages: 455–463, Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Shinichiro Nakajima, Kensuke Nomura, Hiroyoshi Takeuchi, Akira Tanabe, Gohei Yagi and Haruo Kashima

    Version of Record online : 9 JUN 2008, DOI: 10.1002/hup.959

  12. Pharmacological management of aggression and violence

    Human Psychopharmacology: Clinical and Experimental

    Volume 18, Issue 6, August 2003, Pages: 423–436, F. Humble and M. Berk

    Version of Record online : 4 AUG 2003, DOI: 10.1002/hup.504

  13. Worsening of motor features of Parkinsonism with olanzapine

    Movement Disorders

    Volume 14, Issue 6, November 1999, Pages: 1014–1016, Eric S. Molho and Stewart A. Factor

    Version of Record online : 25 JAN 2001, DOI: 10.1002/1531-8257(199911)14:6<1014::AID-MDS1017>3.0.CO;2-9

  14. You have free access to this content
    Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects

    British Journal of Clinical Pharmacology

    Volume 61, Issue 4, April 2006, Pages: 420–426, Jagdev Sidhu, Sarah Job, Jonathan Bullman, Emma Francis, Richard Abbott, John Ascher and Jochen G. W. Theis

    Version of Record online : 24 JAN 2006, DOI: 10.1111/j.1365-2125.2006.02598.x

  15. Bioanalytical methods for the determination of antipsychotic drugs

    Biomedical Chromatography

    Volume 22, Issue 7, July 2008, Pages: 671–687, Guodong Zhang, Alvin V. Terry Jr and Michael G. Bartlett

    Version of Record online : 14 MAR 2008, DOI: 10.1002/bmc.997

  16. You have free access to this content
    Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent

    CNS Drug Reviews

    Volume 6, Issue 4, December 2000, Pages: 303–363, Gary D. Tollefson and Cindy C. Taylor

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2000.tb00155.x

  17. Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 8, August 2011, Pages: 726–735, T. A. Hardy, R. R. Henry, T. D. Forrester, L. A. Kryzhanovskaya, G. M. Campbell, D. M. Marks and S. Mudaliar

    Version of Record online : 21 JUN 2011, DOI: 10.1111/j.1463-1326.2011.01398.x

  18. Pharmacokinetics of Olanzapine After Single-Dose Oral Administration of Standard Tablet Versus Normal and Sublingual Administration of an Orally Disintegrating Tablet in Normal Volunteers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 164–171, Dr John S. Markowitz, Dr C. Lindsay DeVane, Dr Robert J. Malcolm, Ms Holly A. Gefroh, Dr Jun-Sheng Wang, Dr Hao-Jie Zhu and Dr Jennifer L. Donovan

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005283839

  19. Efficacy and safety of novel antipsychotics: a critical review

    Human Psychopharmacology: Clinical and Experimental

    Volume 15, Issue 7, October 2000, Pages: 499–512, Matteo Balestrieri, Claudio Vampini and Cesario Bellantuono

    Version of Record online : 24 OCT 2000, DOI: 10.1002/1099-1077(200010)15:7<499::AID-HUP194>3.0.CO;2-3

  20. Relative bioavailability of olsalazine from tablets and capsules: A drug targeted for local effect in the colon

    Biopharmaceutics & Drug Disposition

    Volume 12, Issue 3, April 1991, Pages: 233–246, M. Ryde, B. Huitfeldt and R. Pettersson

    Version of Record online : 7 FEB 2006, DOI: 10.1002/bdd.2510120308